What move does the options market price into Biocryst Pharmaceuticals's report?

Implied ±22.1%, either direction · provisional.

How often does Biocryst Pharmaceuticals move more than the options market prices?

2 of the last 8 reports moved at least as far as the implied move.

BCRXNasdaqBiological Products, (No Diagnostic Substances)

Biocryst Pharmaceuticals Inc (BCRX) earnings date, market-implied expected move, and options open interest by expiry

8.60

pre 8.55 −0.23%

Pre-market09:05 ETdelayed

Open8.80Volume6.5MMkt cap$2.2BEPS-1.43

Day8.55 – 8.800%52-wk6.23 – 11.2246%

BCRX

Biocryst Pharmaceuticals Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±22.1%implied · straddle

6.6810.46

spot 8.57exp Mar 19ATM strike 9ATM straddle 2.22IV 52%

Nov 3 closeprovisional

Expected move

Inputs

Next report

Feb 25

before open · in 113 days

est.Q4 FY26

Calendar

Next report

Last report

Nov 4

before open

confirmedNov 3 close

Implied vs realized

Largest filed tie

—

13F top-10 QoQ

+7.45%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

Top fund weight

0.89%

BCRX weight · XBI

N-PORTJun 30 '26

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Biocryst Pharmaceuticals (BCRX) is expected to report on Feb 25 before open (estimated date).

Implied vs realized

8 reports

2 of 8≥ implied

avg implied: ±11.5%
avg realized: ±7.6%

May 5 '25May 5 '25confirmed±10.6%▲+23.52%×2.22

Aug 4 '25Aug 4 '25confirmed±24.6%▲+9.81%×0.40

Oct 14 '25Oct 14 '25confirmed±8.6%▼−8.81%×1.02

Nov 3 '25Nov 3 '25confirmed±14.2%▼−6.28%×0.44

Jan 12 '26Jan 12 '26confirmed±7.9%▼−4.80%×0.61

Q1 FY26Feb 26 '26confirmed±7.0%▲+4.64%×0.66

May 6 '26May 6 '26confirmed±8.9%▼−2.21%×0.25

Q2 FY26Aug 5 '26confirmed±10.0%▲+0.55%×0.05

quarterimplied−25%0+25%realized×

Q2 FY26±10.0%▲+0.55%×0.05

May '26±8.9%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 5 expiries · Nov 2 close

0.09OI · 5 expiries · Nov 2 closeP/C open interest · Mar 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

332+13%Nov 2016d0.056,3520%0.05

1,4710%Dec 1844d0.217,1670%0.21

2,4130%Jan 1572d0.1122,4000%0.11

report · Feb 25 · before open · est.

890%Mar 19135d1,0160%

53+2%Apr 16163d0.077920%0.07

ExpiryPutsCallsP/C

Nov 2016d332+13%6,3520%0.05

Dec 1844d1,4710%7,1670%0.21

Jan 1572d2,4130%22,4000%0.11

report · Feb 25 · before open · est.

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±22.1%

Funds 4

XBI±0.2%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

35.92%as filednet margin · revenue +39.53% QoQ · +33.61% YoY

Revenue

$218M+39.53% QoQ

Gross profit

$214M+41.96% QoQ

98.24% margin

Operating income

$98M+114.03% QoQ

45.12% margin

Pre-tax income

$79M+111.03% QoQ

Net income

$78M+110.86% QoQ

35.92% margin

Cost of revenue

$4M−28.58% QoQ

Operating expenses

$116M−86.40% QoQ

SG&A $64M

R&D $52M

Other expense

$19M

Tax

$1M+7.47% QoQ

Revenue$218M+39.53%

Gross profit

$214M+41.96%

98.24% margin

Operating income

$98M+114.03%

45.12% margin

Pre-tax income

$79M+111.03%

Net income

$78M+110.86%

35.92% margin

Cost of revenue

$4M−28.58%

Operating expenses

$116M−86.40%

SG&A $64M

R&D $52M

Other expense

$19M

Tax$1M+7.47%

flow · deduction · signed % = QoQSource: SEC filings · standardized · QE Jun 30 '26 · width = $

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 09:00 ET

Intraday

Event sensitivity

PPI ×1.83· ±4.5% vs ±2.5% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±4.5%5 of 10×1.83

CPIconsumer prices±2.4%3 of 10×0.98

FOMCrate decision±2.1%12 of 24×0.85

NFPjobs report±1.8%4 of 10×0.71

PCEpersonal income & outlays±1.4%7 of 19×0.58

GDPgross domestic product±1.4%8 of 19×0.57

CPROFcorporate profits±0.9%5 of 12×0.37

Bar = avg |move| to ±5% · tick = ±2.5% avg day · ×base = |move| ÷ ±2.5% · min 6 releases

Earnings history

EPS 0.30 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 5 '26 · confirmed	0.30	—
Q1 FY26	Feb 26 '26 · confirmed	-2.98	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod